Andira Medicine Inc. — Form D/A
Andira Medicine Inc. of North Vancouver, A1, a company, filed a Form D amendment with the SEC on 2025-09-05. The offering totals $1.6M, of which $810K was reported sold. Industry: Other.
Offering
- Filed: 2025-09-05
- Form: D/A
- Accession: 0000912282-25-000969
- Industry: Other
- Exemptions: 06b
- Total offering: $1.6M
- Amount sold: $810K
- Remaining: $810K
- Investors: 5
- Date of first sale: 2024-08-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-523370
Issuer
- Name: Andira Medicine Inc.
- CIK: 0001916630
- Entity type: Corporation
- Jurisdiction: BRITISH COLUMBIA, CANADA
- Address: 507-725 Marine Drive, North Vancouver, A1, V7M 0G2
- Phone: 604-335-6348
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Dana Lambert | Director | North Vancouver, A1 |
| Ethan Russo | Director | North Vancouver, A1 |
| Michael Stuart Wall | Director | North Vancouver, A1 |
| Dana Lambert | Executive Officer | North Vancouver, A1 |
| Janette Stuart Lyons | Executive Officer | North Vancouver, A1 |
| Ammad Stuart Shorbaji | Executive Officer | North Vancouver, A1 |
| Evelina Stuart Rubinchik | Executive Officer | North Vancouver, A1 |
Other filings by this issuer (5)
More